Clinical trial
Safety and Effectiveness Study of the HERCULINK 14 Stent to Treat Renal Artery…
NCT00180544 · Abbott Medical Devices, Industry · Terminated
Key facts
| NCT number | NCT00180544 |
|---|---|
| Title | Safety and Effectiveness Study of the HERCULINK 14 Stent to Treat Renal Artery Disease |
| Official title | A Prospective, Non-Randomized, Multicenter, Single-Arm, Clinical Trial to Assess the Safety and Efficacy of the RX HERCULINK 14 Peripheral Stent System for Treatment in de Novo or Restenotic Renal Artery Stenosis |
| Acronym | HERCULINK 14 |
| Lead sponsor | Abbott Medical Devices, Industry |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Renal Artery Obstruction |
| Intervention type | Device |
| Interventions | Stenting: Renal Artery |
| Enrollment | 167 |
| Start date | Jul 1, 2000 |
| Primary completion | Aug 1, 2004 |
| Completion | Aug 1, 2004 |
| First posted | Sep 16, 2005 |
| Last update posted | Jul 28, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: